Related Experiment Videos
Phospholipid molecular species from human placenta lipids
Y Bayon1, M Croset, V Chirouze
1INSERM U 352, Chimie Biologique INSA-Lyon, Villeurbanne, France.
Lipids
|July 1, 1993
Summary
Human placenta lipids are rich in essential polyunsaturated fatty acids (PUFA), particularly n-3 and n-6 long-chain PUFA. This composition suggests placental phospholipids could fortify infant formulas for improved infant nutrition.
Area of Science:
- Lipidomics
- Human Placental Biochemistry
- Nutritional Science
Background:
- Phospholipids are crucial components of cell membranes and play vital roles in infant development.
- Human milk is the primary source of essential fatty acids for newborns, but formula supplementation is often necessary.
- Understanding the lipid profile of the placenta is important for assessing its nutritional contribution and potential applications.
Purpose of the Study:
- To analyze the molecular species and fatty acid composition of phospholipids from human placenta lipids.
- To evaluate the potential of placental phospholipids as a source of long-chain polyunsaturated fatty acids (PUFA) for infant nutrition.
Main Methods:
- Large-scale preparation and analysis of lipid extracts from human placenta.
- Detailed characterization of phospholipid classes, subclasses, and their fatty acid profiles using advanced analytical techniques.
Main Results:
- Choline glycerophospholipids (CPL), sphingomyelin, and ethanolamine glycerophospholipids (EPL) were the major placental phospholipids.
- Total phospholipids exhibited a consistent high level of polyunsaturated fatty acids (PUFA), predominantly 20:4n-6 and 22:6n-3.
- Specific subclasses, like 1-alk-1'-enyl-2-acyl-glycerophosphoethanolamine and diacyl glycerophosphoinositol, showed high concentrations of arachidonic acid and specific fatty acids.
Conclusions:
- Human placental phospholipids are a rich source of essential n-3 and n-6 long-chain PUFA.
- The consistent composition and availability suggest placental phospholipids are a viable option for fortifying artificial milk preparations.
- Supplementation with placental phospholipids may support newborn infants with immature fatty acid desaturation and elongation pathways.